HEADER TRANSFERASE 20-MAR-06 2GEU TITLE PANTOTHENATE KINASE FROM MYCOBACTERIUM TUBERCULOSIS (MTPANK) IN TITLE 2 COMPLEX WITH A COENZYME A DERIVATIVE, FORM-II (RT) COMPND MOL_ID: 1; COMPND 2 MOLECULE: PANTOTHENATE KINASE; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: PANK, PANTOTHENIC ACID KINASE; COMPND 5 EC: 2.7.1.33; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: MYCOBACTERIUM TUBERCULOSIS; SOURCE 3 ORGANISM_TAXID: 83332; SOURCE 4 STRAIN: H37RV; SOURCE 5 GENE: COAA(RV1092C); SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21 (DE3); SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PET-28A(+) (NOVAGEN) KEYWDS HOMODIMER, COA BIOSYNTHESIS, NUCLEOTIDE BINDING, TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR S.DAS,P.KUMAR,V.BHOR,A.SUROLIA,M.VIJAYAN REVDAT 6 23-OCT-24 2GEU 1 REMARK REVDAT 5 25-OCT-23 2GEU 1 REMARK SEQADV LINK REVDAT 4 18-OCT-17 2GEU 1 REMARK REVDAT 3 13-JUL-11 2GEU 1 VERSN REVDAT 2 24-FEB-09 2GEU 1 VERSN REVDAT 1 06-JUN-06 2GEU 0 JRNL AUTH S.DAS,P.KUMAR,V.BHOR,A.SUROLIA,M.VIJAYAN JRNL TITL INVARIANCE AND VARIABILITY IN BACTERIAL PANK: A STUDY BASED JRNL TITL 2 ON THE CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PANK. JRNL REF ACTA CRYSTALLOGR.,SECT.D V. 62 628 2006 JRNL REFN ISSN 0907-4449 JRNL PMID 16699190 JRNL DOI 10.1107/S0907444906012728 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH S.DAS,P.KUMAR,V.BHOR,A.SUROLIA,M.VIJAYAN REMARK 1 TITL EXPRESSION, PURIFICATION, CRYSTALLIZATION AND PRELIMINARY REMARK 1 TITL 2 X-RAY CRYSTALLOGRAPHIC ANALYSIS OF PANTOTHENATE KINASE FROM REMARK 1 TITL 3 MYCOBACTERIUM TUBERCULOSIS REMARK 1 REF ACTA CRYSTALLOGR.,SECT.F V. 61 65 2005 REMARK 1 REFN ESSN 1744-3091 REMARK 1 PMID 16508093 REMARK 1 DOI 10.1107/S1744309104028040 REMARK 2 REMARK 2 RESOLUTION. 2.90 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 1.1 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : ENGH & HUBER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.90 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 19.57 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 1379977.980 REMARK 3 DATA CUTOFF LOW (ABS(F)) : 0.0000 REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 98.9 REMARK 3 NUMBER OF REFLECTIONS : 13506 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.183 REMARK 3 FREE R VALUE : 0.221 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.100 REMARK 3 FREE R VALUE TEST SET COUNT : 685 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.008 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 10 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.90 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 3.00 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 99.40 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 1266 REMARK 3 BIN R VALUE (WORKING SET) : 0.3170 REMARK 3 BIN FREE R VALUE : 0.3660 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 5.60 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 75 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.042 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2448 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 52 REMARK 3 SOLVENT ATOMS : 86 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 72.20 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 58.20 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 8.25000 REMARK 3 B22 (A**2) : 8.25000 REMARK 3 B33 (A**2) : -16.50000 REMARK 3 B12 (A**2) : 14.65000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.31 REMARK 3 ESD FROM SIGMAA (A) : 0.47 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.39 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.52 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.007 REMARK 3 BOND ANGLES (DEGREES) : 1.400 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 25.00 REMARK 3 IMPROPER ANGLES (DEGREES) : 0.890 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : GROUP REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : FLAT MODEL REMARK 3 KSOL : 0.27 REMARK 3 BSOL : 34.55 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP+CME.PARAM REMARK 3 PARAMETER FILE 2 : WATER_REP.PARAM REMARK 3 PARAMETER FILE 3 : ION.PARAM REMARK 3 PARAMETER FILE 4 : DRGCNS_COA_2ME.PARAM REMARK 3 PARAMETER FILE 5 : NULL REMARK 3 TOPOLOGY FILE 1 : PROTEIN+CME.TOP REMARK 3 TOPOLOGY FILE 2 : NULL REMARK 3 TOPOLOGY FILE 3 : NULL REMARK 3 TOPOLOGY FILE 4 : NULL REMARK 3 TOPOLOGY FILE 5 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 2GEU COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 23-MAR-06. REMARK 100 THE DEPOSITION ID IS D_1000037030. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 16-MAY-04 REMARK 200 TEMPERATURE (KELVIN) : 293.0 REMARK 200 PH : 6.50 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU ULTRAX 18 REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : OSMIC MIRROR REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : MAR SCANNER 345 MM PLATE REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK, CCP4 (TRUNCATE) REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 13523 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.900 REMARK 200 RESOLUTION RANGE LOW (A) : 19.570 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.0 REMARK 200 DATA REDUNDANCY : 4.700 REMARK 200 R MERGE (I) : 0.08800 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 14.0000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.90 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 3.00 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.7 REMARK 200 DATA REDUNDANCY IN SHELL : 4.70 REMARK 200 R MERGE FOR SHELL (I) : 0.53600 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 3.300 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: AMORE REMARK 200 STARTING MODEL: PDB ID 1ESM REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 69.80 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 4.10 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 10-15%(W/V) PEG8000, 0.05M NACL, 0.05 REMARK 280 -0.1M NAOAC IN 0.1 M NA-CACODYLATE BUFFER OF PH 6.5, 0.001M BETA- REMARK 280 MERCAPTOETHANOL WAS PRESENT IN THE PROTEIN BUFFER, PH 6.50, REMARK 280 VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 31 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z+1/3 REMARK 290 3555 -X+Y,-X,Z+2/3 REMARK 290 4555 Y,X,-Z REMARK 290 5555 X-Y,-Y,-Z+2/3 REMARK 290 6555 -X,-X+Y,-Z+1/3 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 29.95000 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 59.90000 REMARK 290 SMTRY1 4 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 4 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 5 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 59.90000 REMARK 290 SMTRY1 6 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 6 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 29.95000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 300 REMARK: THE FOLLOWING SYMMETRY OPERATION WILL GENERATE THE SECOND REMARK 300 SUBUNIT OF THE HOMODIMERIC MTPANK MOLECULE: SYMMETRY:-X, -X+Y, -Z+1/ REMARK 300 3; TRANSSYMM: 765 REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA,PQS REMARK 350 TOTAL BURIED SURFACE AREA: 6950 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 26150 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -41.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 -0.500000 -0.866025 0.000000 161.45100 REMARK 350 BIOMT2 2 -0.866025 0.500000 0.000000 93.21378 REMARK 350 BIOMT3 2 0.000000 0.000000 -1.000000 29.95000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 1 REMARK 465 SER A 2 REMARK 465 ARG A 3 REMARK 465 LEU A 4 REMARK 465 GLN A 82 REMARK 465 GLN A 83 REMARK 465 ASN A 84 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 SER A 5 OG REMARK 470 ARG A 16 CG CD NE CZ NH1 NH2 REMARK 470 GLN A 68 CG CD OE1 NE2 REMARK 470 PRO A 85 CG CD REMARK 470 ASP A 86 CG OD1 OD2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ARG A 69 CG - CD - NE ANGL. DEV. = -13.8 DEGREES REMARK 500 ARG A 69 NE - CZ - NH1 ANGL. DEV. = 3.9 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 GLU A 6 92.31 175.20 REMARK 500 MET A 23 -132.95 66.44 REMARK 500 SER A 24 58.34 -118.27 REMARK 500 LEU A 78 -7.61 -59.44 REMARK 500 ASP A 86 -9.43 -156.00 REMARK 500 ARG A 116 65.02 -104.45 REMARK 500 ASP A 118 -73.53 -3.69 REMARK 500 HIS A 119 -9.75 -55.83 REMARK 500 HIS A 120 73.61 51.15 REMARK 500 HIS A 194 71.71 19.40 REMARK 500 THR A 245 -90.73 -120.58 REMARK 500 PHE A 254 40.39 -107.60 REMARK 500 PRO A 287 -6.56 -59.22 REMARK 500 HIS A 302 1.25 82.00 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE COK A 401 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 2GES RELATED DB: PDB REMARK 900 THE SAME PROTEIN COMPLEXED WITH A COENZYME A DERIVATIVE, FORM-I (RT) REMARK 900 RELATED ID: 2GET RELATED DB: PDB REMARK 900 THE SAME PROTEIN COMPLEXED WITH A COENZYME A DERIVATIVE, FORM-I (LT) REMARK 900 RELATED ID: 2GEV RELATED DB: PDB REMARK 900 THE SAME PROTEIN COMPLEXED WITH A COENZYME A DERIVATIVE, FORM-II REMARK 900 (LT) DBREF 2GEU A 1 312 UNP P63810 COAA_MYCTU 1 312 SEQADV 2GEU CME A 173 UNP P63810 CYS 173 MODIFIED RESIDUE SEQRES 1 A 312 MET SER ARG LEU SER GLU PRO SER PRO TYR VAL GLU PHE SEQRES 2 A 312 ASP ARG ARG GLN TRP ARG ALA LEU ARG MET SER THR PRO SEQRES 3 A 312 LEU ALA LEU THR GLU GLU GLU LEU VAL GLY LEU ARG GLY SEQRES 4 A 312 LEU GLY GLU GLN ILE ASP LEU LEU GLU VAL GLU GLU VAL SEQRES 5 A 312 TYR LEU PRO LEU ALA ARG LEU ILE HIS LEU GLN VAL ALA SEQRES 6 A 312 ALA ARG GLN ARG LEU PHE ALA ALA THR ALA GLU PHE LEU SEQRES 7 A 312 GLY GLU PRO GLN GLN ASN PRO ASP ARG PRO VAL PRO PHE SEQRES 8 A 312 ILE ILE GLY VAL ALA GLY SER VAL ALA VAL GLY LYS SER SEQRES 9 A 312 THR THR ALA ARG VAL LEU GLN ALA LEU LEU ALA ARG TRP SEQRES 10 A 312 ASP HIS HIS PRO ARG VAL ASP LEU VAL THR THR ASP GLY SEQRES 11 A 312 PHE LEU TYR PRO ASN ALA GLU LEU GLN ARG ARG ASN LEU SEQRES 12 A 312 MET HIS ARG LYS GLY PHE PRO GLU SER TYR ASN ARG ARG SEQRES 13 A 312 ALA LEU MET ARG PHE VAL THR SER VAL LYS SER GLY SER SEQRES 14 A 312 ASP TYR ALA CME ALA PRO VAL TYR SER HIS LEU HIS TYR SEQRES 15 A 312 ASP ILE ILE PRO GLY ALA GLU GLN VAL VAL ARG HIS PRO SEQRES 16 A 312 ASP ILE LEU ILE LEU GLU GLY LEU ASN VAL LEU GLN THR SEQRES 17 A 312 GLY PRO THR LEU MET VAL SER ASP LEU PHE ASP PHE SER SEQRES 18 A 312 LEU TYR VAL ASP ALA ARG ILE GLU ASP ILE GLU GLN TRP SEQRES 19 A 312 TYR VAL SER ARG PHE LEU ALA MET ARG THR THR ALA PHE SEQRES 20 A 312 ALA ASP PRO GLU SER HIS PHE HIS HIS TYR ALA ALA PHE SEQRES 21 A 312 SER ASP SER GLN ALA VAL VAL ALA ALA ARG GLU ILE TRP SEQRES 22 A 312 ARG THR ILE ASN ARG PRO ASN LEU VAL GLU ASN ILE LEU SEQRES 23 A 312 PRO THR ARG PRO ARG ALA THR LEU VAL LEU ARG LYS ASP SEQRES 24 A 312 ALA ASP HIS SER ILE ASN ARG LEU ARG LEU ARG LYS LEU MODRES 2GEU CME A 173 CYS S,S-(2-HYDROXYETHYL)THIOCYSTEINE HET CME A 173 10 HET COK A 401 52 HETNAM CME S,S-(2-HYDROXYETHYL)THIOCYSTEINE HETNAM COK [(2R,3S,4R,5R)-5-(6-AMINO-9H-PURIN-9-YL)-4-HYDROXY-3- HETNAM 2 COK (PHOSPHONOOXY)TETRAHYDROFURAN-2-YL]METHYL (3R)-3- HETNAM 3 COK HYDROXY-4-{[3-({2-[(2-HYDROXYETHYL) HETNAM 4 COK DITHIO]ETHYL}AMINO)-3-OXOPROPYL]AMINO}-2,2-DIMETHYL-4- HETNAM 5 COK OXOBUTYL DIHYDROGEN DIPHOSPHATE HETSYN COK S-(THIOETHYLHYDROXY)COENZYME A FORMUL 1 CME C5 H11 N O3 S2 FORMUL 2 COK C23 H40 N7 O17 P3 S2 FORMUL 3 HOH *86(H2 O) HELIX 1 1 ARG A 15 ALA A 20 1 6 HELIX 2 2 LEU A 21 MET A 23 5 3 HELIX 3 3 THR A 30 ARG A 38 1 9 HELIX 4 4 ASP A 45 VAL A 52 1 8 HELIX 5 5 VAL A 52 GLY A 79 1 28 HELIX 6 6 GLY A 102 ARG A 116 1 15 HELIX 7 7 ASP A 129 LEU A 132 5 4 HELIX 8 8 PRO A 134 ASN A 142 1 9 HELIX 9 9 LEU A 143 LYS A 147 5 5 HELIX 10 10 PHE A 149 TYR A 153 5 5 HELIX 11 11 ASN A 154 SER A 167 1 14 HELIX 12 12 MET A 213 PHE A 218 5 6 HELIX 13 13 ARG A 227 MET A 242 1 16 HELIX 14 14 PHE A 254 ALA A 258 5 5 HELIX 15 15 SER A 261 ILE A 276 1 16 HELIX 16 16 ILE A 276 ASN A 284 1 9 HELIX 17 17 ILE A 285 ALA A 292 5 8 SHEET 1 A 7 TYR A 10 ASP A 14 0 SHEET 2 A 7 ILE A 304 ARG A 310 -1 O LEU A 309 N VAL A 11 SHEET 3 A 7 LEU A 294 LYS A 298 -1 N ARG A 297 O ARG A 306 SHEET 4 A 7 PHE A 220 ASP A 225 1 N ASP A 225 O LYS A 298 SHEET 5 A 7 PHE A 91 GLY A 97 1 N GLY A 94 O LEU A 222 SHEET 6 A 7 ILE A 197 GLU A 201 1 O LEU A 200 N ILE A 93 SHEET 7 A 7 VAL A 123 THR A 127 1 N VAL A 126 O ILE A 199 SHEET 1 B 2 ALA A 172 SER A 178 0 SHEET 2 B 2 ASP A 183 VAL A 192 -1 O VAL A 192 N ALA A 172 LINK C ALA A 172 N CME A 173 1555 1555 1.32 LINK C CME A 173 N ALA A 174 1555 1555 1.33 SITE 1 AC1 24 GLY A 39 LEU A 40 VAL A 99 ALA A 100 SITE 2 AC1 24 LYS A 103 SER A 104 ARG A 108 LYS A 147 SITE 3 AC1 24 TYR A 177 HIS A 179 TYR A 182 LEU A 203 SITE 4 AC1 24 TYR A 235 ARG A 238 MET A 242 PHE A 247 SITE 5 AC1 24 PHE A 254 ILE A 272 ASN A 277 HOH A 501 SITE 6 AC1 24 HOH A 540 HOH A 541 HOH A 544 HOH A 556 CRYST1 107.634 107.634 89.850 90.00 90.00 120.00 P 31 2 1 6 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.009291 0.005364 0.000000 0.00000 SCALE2 0.000000 0.010728 0.000000 0.00000 SCALE3 0.000000 0.000000 0.011130 0.00000